nDatalyze Corp.

    nDatalyze Corp.

    CCSE:NDAT
    - -
    CAD
    - -
    - -

    Share Statistics

    As of May 31, 2025, nDatalyze Corp. has 41.33M shares outstanding.

    Shares Outstanding41.33M

    Valuation Ratios

    These figures are as of May 31, 2025. The price-to-sales ratio is 706.72, and the price-to-book ratio stands at 1.23.

    PS Ratio706.72
    PB Ratio1.23
    P/TBV Ratio1.29
    P/FCF Ratio-1.78
    P/OCF Ratio-1.78

    Financial Position

    As of May 31, 2025, nDatalyze Corp. maintains a current ratio of 21.60, meaning it holds 21.6x the short-term assets needed to cover near-term liabilities.

    Current Ratio21.60
    Quick Ratio21.60
    Interest Coverage-544.43

    Financial Efficiency

    Over the twelve months ended May 31, 2025, nDatalyze Corp. posted a negative return on equity (ROE) of -57.74, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -55.21, reflecting losses generated across the asset base. Return on capital employed (ROCE) is negative at -155.37, pointing to unprofitable operations over the period.

    Return on Equity (ROE)-57.74
    Return on Assets (ROA)-55.21
    Return on Capital Employed (ROCE)-155.37

    Margins

    Over the twelve months ended May 31, 2025, nDatalyze Corp. posted a gross margin of 81.85, reflecting its pricing power and cost economics. The operating margin of -52,814.32 and net profit margin of -43,676.55 provide insight into operational efficiency.

    Gross Margin81.85
    Operating Margin-52,814.32
    Pretax Margin-43,676.55
    Profit Margin-43,676.55
    EBITDA Margin-52,601.35

    Dividends & Yields

    These figures cover the twelve months ended May 31, 2025. Free cash flow yield is negative at -56.02: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

    FCF Yield-56.02

    Scores

    As of May 31, 2025, nDatalyze Corp. has an Altman Z-Score of 2.53, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

    Altman Z-Score2.53